SMS PHARMACEUTICALS LTD. - 532815 - Fixation Of AGM Date, Book Closure And Record Date For AGM
Fixation of AGM date, Book Closure and Record Date for AGM13-08-2022
SMS PHARMACEUTICALS LTD. - 532815 - Fixation Of AGM Date, Book Closure And Record Date For AGM
Fixation of AGM date, Book Closure and Record Date for AGMSMS PHARMACEUTICALS LTD. - 532815 - Financial Results For The First Quarter Ended 30Th June, 2022
Financial Results for the first quarter ended 30th June, 2022SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Board Meeting Held On 13-Aug-2022 To Consider Financial Statements For The Period Ended June 2022 And Other Business Matters
SMS Pharmaceuticals Limited has informed the Exchange about Board Meeting held on 13-Aug-2022 to consider financial statements for the period ended June 2022 and Other business mattersSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor's Conference CallSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Change in Directorate
Withdrawal of Nomination of Mrs. Shilpa R Waghmare as Nominee Director of the CompanySMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Approval Of Un Audited Financial Results For The Quarter Ended 30Th June 2022
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 ,inter alia, to consider and approve un audited financial results for the quarter ended 30th June 2022SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Receipt of CEP approvalSMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2022.SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2022.SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window
Intimation of Closure of trading window